CNTMF.US Cansortium Inc

Healthcare Pharmaceuticals USA Stocks
0.0166 USD
Close of Nov 11, 2026
0.0100 0.0840
Market cap
USD 10.2M
P/E
-
P/B
8.65x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is CNTMF.US undervalued?

Graham number

The Graham number of Cansortium Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cansortium Inc fundamental analysis

No fundamental analysis for Cansortium Inc yet.

Cansortium Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cansortium Inc

FLUENT Corp., through its subsidiaries, cultivates, manufactures, processes, distributes, and sells medical cannabis products for medical and adult-use in the United States. Its medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, concentrates, and edibles. The company also sells various third-party branded medical cannabis products, as well as other accessories. It offers its products under the Bag-O, FLUENT…

Full company profile